Ticker: AUPH

Company: Aurinia Pharmaceuticals Inc.

Person: Peter Greenleaf, director, officer

Transaction date: Feb. 20, 2026

Reporting date: Feb. 23, 2026

Average share price: 14.400000000000002

Sold 100171.0 shares for 1442462.4